|drug3727||Standard mouthpiece Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
Due to the concerns of virus transmission during COVID-19 pandemic, multiple respiratory societies postpone or limit pulmonary function test, especially cardiopulmonary exercise test (CPET), as patients may generate large amount of aerosol particles during test but it is conventionally performed without filter. This study aims to investigate the effects of reducing aerosol particle concentrations in the room air during CPET by placing an inline filter, and to assess the effects of filter on the physiologic responses during CPET.
Description: The concentrations of aerosol particles generated by subjects during CPET will be recorded continuously for 45 minutesMeasure: Aerosol particle concentrations during CPET Time: 45 minutes
Description: The concentrations of aerosol particles in the room air will be recorded continuously for 1 hour after CPET is completedMeasure: Aerosol particle concentrations within 1 hour after CPET is completed Time: 1 hour
Description: Patients' minute ventilation during CPET will be recorded continuouslyMeasure: minute ventilation during CPET Time: 45 minutes
Description: Patients' oxygen uptake during CPET will be recorded continuouslyMeasure: oxygen uptake during CPET Time: 45 minutes
Description: Patients' carbon dioxide during CPET will be recorded continuouslyMeasure: carbon dioxide output during CPET Time: 45 minutes
Description: Patients' heart rate during CPET will be recorded continuouslyMeasure: Heart rate during CPET Time: 45 minutes
Description: Borg dyspnea score is a scale that asks the subject to rate the difficulty of his/her breathing. It starts at number 0 where the breathing is causing him/her no difficulty at all and progresses through to number 10 where his/her breathing difficulty is maximal.Measure: Borg dyspnea score during CPET Time: 45 minutes
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports